Search
Lung Cancer Paid Clinical Trials in Massachusetts
A listing of 137 Lung Cancer clinical trials in Massachusetts actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
133 - 137 of 137
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Lung Cancer
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
The state of Massachusetts currently has 137 active clinical trials seeking participants for Lung Cancer research studies. These trials are conducted in various cities, including Boston, Worcester, Springfield and Burlington.
Featured Trial
Major Depressive Disorder Clinical Study
Recruiting
Is depression weighing you down? Local major depressive disorder clinical studies are now enrolling participants in the area. Participating in research studies helps contribute to the advancement of future medicine and treatment options. There is no obligation to take part and health insurance is not required.
Conditions:
Major Depressive Disorder
Major Depression
Major Depressive Episode
Major Depressive Disorder (MDD)
Major Depressive Disorders
Featured Trial
Hyperacusis Activities Treatment-Online Study
Recruiting
Are you experiencing hyperacusis? If so, we are recruiting adults with hyperacusis to complete a clinical trial supported by the National Institutes of Health. The study involves participating in a remote counseling program and sound therapy trial for hyperacusis, Hyperacusis Activities Treatment-Online.
Conditions:
Hyperacusis
Tinnitus
Hearing Loss
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Irritability Associated with Autism (Children and Adolescents) Study
Recruiting
Become part of a clinical trial today and play a role in driving medical research forward, aiding in the discovery of groundbreaking therapies. Get rewarded for your time with monetary compensation and enjoy access to medical treatment at no charge.
The Transitions Project: Efficacy Trial
Recruiting
The aim of this study is to evaluate the efficacy of a brief psychoeducational intervention to improve quality of life in patients with lung cancer who are transitioning from active treatment to surveillance.
Gender:
All
Ages:
21 years and above
Trial Updated:
11/09/2022
Locations: Massachusetts General Hospital Cancer Center, Boston, Massachusetts +1 locations
Conditions: Lung Cancer
Pilot Study of Biopsy Scanner for Evaluation of Bronchoscopic Small Biopsy Specimens to Determine Adequacy
Recruiting
The aim of the study is to assess the performance of Aquyre Biopsy Scanner technology (the FDA class I medical device) at determining if tissue from the lymph nodes and lung nodules, taken during a bronchoscopy procedure, is adequate for a diagnosis. The study will assess how well the Aquyre Biopsy Scanner can differentiate between tissue samples that meet certain requirements that allow for further diagnostic analysis and samples that do not.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/24/2022
Locations: Boston Medical Center, Boston, Massachusetts
Conditions: Lung Cancer
DNA Analysis of Blood and Tissue From Patients With Lung Cancer
Recruiting
RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help the study of cancer in the future.
PURPOSE: This clinical trial is analyzing the DNA in blood and tissue samples from patients with lung cancer.
Gender:
All
Ages:
Between 18 years and 120 years
Trial Updated:
04/14/2022
Locations: Massachusetts General Hospital, Boston, Massachusetts +1 locations
Conditions: Lung Cancer
Molecular and Genetic Analysis of Lung Cancer
Recruiting
Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/14/2022
Locations: Massachusetts General Hospital, Boston, Massachusetts
Conditions: Lung Cancer
Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer
Recruiting
This research study is studying a combination of drugs as a possible treatment for EGFR-Mutated Advanced Lung Cancer.
The names of the study drugs involved in this study are Niraparib and Osimertinib.
Gender:
All
Ages:
18 years and above
Trial Updated:
12/14/2020
Locations: Dana Farber Cancer Institute, Boston, Massachusetts +2 locations
Conditions: Lung Cancer
133 - 137 of 137